关键词：血红蛋白检测仪；四聚体蛋白质；医疗器械；检测手段；糖尿病
摘 要：Hemoglobin A is the most common tetramer protein found in red blood cells. In case of traces of glucose in the bloodstream, the glucose sticks to the hemoglobin, and hemoglobin proteins become glycated. The HbA1c test measures of percentage of glycated hemoglobin in blood over a period of approximately three months (the life-span of an average red blood cell). The test is a good general measure for diabetes care. For a person without diabetes, a typical HbA1c level reading amounts to 5 percent, while the reading is 8 percent or more for patients with poorly controlled diabetes and less than 7 percent for patients with well controlled diabetes. HbA1c testing is a standardized test recommended by physicians for the diagnosis of type 2 diabetes, or to test patients who are prone to developing diabetes.The Global Glycated Hemoglobin Testing market is expected to grow at a steady pace during the period 2012–2016. The market was dominated by the Americas in 2012, followed by the EMEA and APAC regions. HbA1c POC testing is the fastest growing segment that is expected to make significant contributions to the revenue of the overall market over the next few years. The Global Advanced Wound Management market is expected to post a CAGR of 10.1 percent during the forecast period.
目 录：

01. Executive Summary

02. Scope of the Report

02.1 Market Overview

02.2 Product Offerings

03. Market Research Methodology

03.1 Market Research Process

03.2 Research Design

03.3 Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Criteria

07.1 Global HbA1c POC Testing Market

07.2 Global HbA1c Laboratory Testing Market

08. Market Segmentation by Method

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2012

17.3 Other Prominent Vendors

17.3.1 Product Portfolio

18. Key Vendor Analysis

18.1 Abbott Laboratories

18.1.1 Business Overview

18.1.2 Business Segmentation

18.1.3 Key Information

18.1.4 SWOT Analysis

18.2 Alere Inc.

18.2.1 Business Overview

18.2.2 Business Segmentation

18.2.3 Key Information

18.2.4 SWOT Analysis

18.3 Beckman Coulter Inc.

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Roche Holdings AG

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

19. Other Reports in this Serie